Vitaliy Mykytiv

Cork, M, Ireland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

SKY92 Identifies High-Risk Newly Diagnosed Multiple Myeloma With Inferior Progression-Free Survival and Implicates NUF2 as a Candidate Driver.

SKY92 Identifies High-Risk Newly Diagnosed Multiple Myeloma With Inferior Progression-Free Survival and Implicates NUF2 as a Candidate Driver.

Journal: European journal of haematology

Published: June 30, 2026

Drug-induced plasma discolouration mimicking icterus risks inappropriate withholding of critical lactate.

Drug-induced plasma discolouration mimicking icterus risks inappropriate withholding of critical lactate.

Journal: Practical laboratory medicine

Published: March 12, 2026

Enhanced Detection of Multiple Myeloma Cells by Next-Generation Flow Cytometry Following Density Gradient Medium Separation.

Enhanced Detection of Multiple Myeloma Cells by Next-Generation Flow Cytometry Following Density Gradient Medium Separation.

Journal: European journal of haematology

Published: July 28, 2025

Acute Myeloid Leukaemia With Morphologic and Immunophenotypic Differentiation to Acute Erythroid Leukaemia at the Time of Relapse.

Acute Myeloid Leukaemia With Morphologic and Immunophenotypic Differentiation to Acute Erythroid Leukaemia at the Time of Relapse.

Journal: International journal of laboratory hematology

Published: April 28, 2024

Blood Cancer Network Ireland (BCNI) and National Cancer Registry Ireland (NCRI) collaboration: challenges and utility of an Enhanced Blood Cancer Outcomes Registry (EBCOR) pilot.

Blood Cancer Network Ireland (BCNI) and National Cancer Registry Ireland (NCRI) collaboration: challenges and utility of an Enhanced Blood Cancer Outcomes Registry (EBCOR) pilot.

Journal: Irish journal of medical science

Published: March 22, 2024

It's in the blood: a review of the hematological system in SARS-CoV-2-associated COVID-19.

It's in the blood: a review of the hematological system in SARS-CoV-2-associated COVID-19.

Journal: Critical reviews in clinical laboratory sciences

Published: July 13, 2023

The impact of expanded access programs for systemic anticancer therapy in an Irish cancer centre.

The impact of expanded access programs for systemic anticancer therapy in an Irish cancer centre.

Journal: Irish journal of medical science

Published: June 07, 2023

Calculated Globulin as a potential screening tool for paraproteinemia to aid in the early diagnosis of Multiple Myeloma.

Calculated Globulin as a potential screening tool for paraproteinemia to aid in the early diagnosis of Multiple Myeloma.

Journal: Clinical biochemistry

Published: December 29, 2022

A panhaemocytometric approach to COVID-19: the importance of cell population data on Sysmex XN-series analysers in severe disease.

A panhaemocytometric approach to COVID-19: the importance of cell population data on Sysmex XN-series analysers in severe disease.

Journal: Clinical chemistry and laboratory medicine

Published: October 22, 2022

Management of a patient with acute myeloid leukaemia with a diagnosis of type 2 von Willebrand disease and a novel variant within the von Willebrand factor (VWF) gene.

Management of a patient with acute myeloid leukaemia with a diagnosis of type 2 von Willebrand disease and a novel variant within the von Willebrand factor (VWF) gene.

Journal: British journal of haematology

Published: July 07, 2022

CyBorD-DARA in Newly Diagnosed Transplant-Eligible Multiple Myeloma: Results from the 16-BCNI-001/CTRIAL-IE 16-02 Study Show High Rates of MRD Negativity at End of Treatment.

CyBorD-DARA in Newly Diagnosed Transplant-Eligible Multiple Myeloma: Results from the 16-BCNI-001/CTRIAL-IE 16-02 Study Show High Rates of MRD Negativity at End of Treatment.

Journal: Clinical lymphoma, myeloma & leukemia

Published: April 06, 2022

Minimal Residual Disease in Multiple Myeloma: Potential for Blood-Based Methods to Monitor Disease.

Minimal Residual Disease in Multiple Myeloma: Potential for Blood-Based Methods to Monitor Disease.

Journal: Clinical lymphoma, myeloma & leukemia

Published: May 31, 2021

Showing 1-12 of 24

Last Updated: 09/26/2026